Abstract
We report a 47-year-old woman who developed features of rheumatoid arthritis 20 weeks after initiation of treatment with pegylated interferon and ribavirin for chronic hepatitis C. She continued to have symptoms six months after discontinuation of the drugs which she received for 24 weeks with rival clearance.
MeSH terms
-
Antiviral Agents / adverse effects*
-
Arthritis, Rheumatoid / chemically induced*
-
Female
-
Hepatitis C, Chronic / drug therapy*
-
Humans
-
Interferon alpha-2
-
Interferon-alpha / adverse effects*
-
Middle Aged
-
Polyethylene Glycols / adverse effects*
-
Recombinant Proteins
Substances
-
Antiviral Agents
-
Interferon alpha-2
-
Interferon-alpha
-
Recombinant Proteins
-
Polyethylene Glycols
-
peginterferon alfa-2a